Company Filing History:
2 out of 1,217 
1 out of 28 
Years Active: 1996-1999
Title: Matteo Schaffhauser: Innovator in Aldose Reductase Inhibition
Introduction
Matteo Schaffhauser is a notable inventor based in Bern, Switzerland. He has made significant contributions to the field of diabetes treatment through his innovative research and patents. With a total of 3 patents, Schaffhauser has focused on methods to inhibit aldose reductase, a key enzyme involved in diabetic complications.
Latest Patents
Schaffhauser's latest patents include a method of inhibiting aldose reductase in vivo with intrinsic inhibitors. This patent describes the isolation and purification of an intrinsic aldose reductase inhibitor from mammalian cells, such as rat or human kidney cells. The intrinsic aldose reductase inhibitor can be incorporated into pharmaceutical compositions for treating conditions related to diabetes. Another patent details the process for making these intrinsic inhibitors, emphasizing their potential therapeutic applications.
Career Highlights
Throughout his career, Schaffhauser has worked with various organizations, including the United States of America as represented by the Department of Health. His work has contributed to advancements in diabetes treatment and has garnered attention in the scientific community.
Collaborations
Some of Schaffhauser's notable coworkers include Peter F. Kador and Yukio Takahashi. Their collaborative efforts have furthered research in the field of aldose reductase inhibition.
Conclusion
Matteo Schaffhauser's innovative work in aldose reductase inhibition has the potential to significantly impact diabetes treatment. His patents reflect a commitment to advancing medical science and improving patient outcomes.